Adtalem Global Education (NYSE:CVSA) Releases FY 2026 Earnings Guidance

Adtalem Global Education (NYSE:CVSA) updated its FY 2026 earnings guidance on Thursday. The company provided EPS guidance of 7.950-8.150 for the period, compared to the consensus EPS estimate of 7.900. The company issued revenue guidance of $1.9 billion-$1.9 billion, compared to the consensus revenue estimate of $1.9 billion.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on CVSA. Weiss Ratings began coverage on shares of Adtalem Global Education in a research note on Wednesday, February 25th. They issued a “hold (c+)” rating on the stock. Barrington Research restated an “outperform” rating and issued a $170.00 target price on shares of Adtalem Global Education in a report on Friday, April 17th. Zacks Research cut shares of Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a report on Wednesday, March 25th. Finally, Truist Financial started coverage on shares of Adtalem Global Education in a report on Tuesday, March 24th. They issued a “buy” rating and a $130.00 target price on the stock. Two analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Adtalem Global Education presently has an average rating of “Moderate Buy” and an average price target of $150.00.

Adtalem Global Education Stock Performance

Shares of CVSA traded up $12.42 during trading hours on Friday, hitting $129.42. The company had a trading volume of 416,744 shares, compared to its average volume of 390,335. The company’s fifty day moving average is $110.78. The company has a quick ratio of 0.68, a current ratio of 0.68 and a debt-to-equity ratio of 0.37. The stock has a market capitalization of $4.47 billion, a PE ratio of 19.07, a price-to-earnings-growth ratio of 0.98 and a beta of 0.63. Adtalem Global Education has a 52-week low of $86.97 and a 52-week high of $156.26.

Adtalem Global Education (NYSE:CVSA) last issued its earnings results on Thursday, May 7th. The company reported $1.98 earnings per share for the quarter, topping analysts’ consensus estimates of $1.73 by $0.25. Adtalem Global Education had a return on equity of 20.24% and a net margin of 13.41%.The business had revenue of $487.03 million during the quarter. During the same period last year, the firm posted $1.92 EPS. Adtalem Global Education’s quarterly revenue was up 4.5% compared to the same quarter last year. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. Research analysts anticipate that Adtalem Global Education will post 7.86 earnings per share for the current fiscal year.

Insider Activity

In other news, Director Michael W. Malafronte purchased 8,890 shares of the business’s stock in a transaction on Wednesday, March 11th. The stock was acquired at an average cost of $100.94 per share, for a total transaction of $897,356.60. Following the purchase, the director directly owned 25,395 shares in the company, valued at $2,563,371.30. This trade represents a 53.86% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In the last ninety days, insiders bought 37,236 shares of company stock worth $3,752,866. Insiders own 2.50% of the company’s stock.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.